A carregar...

Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX(®) Modified Release Tablets in Healthy Male and Female Volunteers

The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enrolled healthy men and post-menopausal women received modified release tablets containing 600 mg of the oral non-absorbable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antibiotics (Basel)
Main Authors: Di Stefano, Andrea Francesco Daniele, Radicioni, Milko Massimiliano, Vaccani, Angelo, Mazzetti, Alessandro, Longo, Luigi Maria, Moro, Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7915865/
https://ncbi.nlm.nih.gov/pubmed/33562091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10020167
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!